Evidence map›Paper›PMID 42058195›Full record

ArticleFrontiers in immunology2026

X-linked severe combined immunodeficiency due to

Bricia Melissa Gutiérrez-Zepeda, Juan Carlos Lona-Reyes, Mario Ernesto Cruz-Muñoz, Antonio Quintero-Ramos, Carlos Torres-Lozano, Beatriz Bayardo-Gutierrez, Alejandro Barrón-Balderas, Sergio D Rosenzweig, Jennifer Stoddard, Julie Niemela and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bricia Melissa Gutiérrez-ZepedaDoctorado en Genética Humana, Departamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
Juan Carlos Lona-ReyesDepartamento de Infectología, Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Guadalajara, Mexico.
Mario Ernesto Cruz-MuñozFacultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico.
Antonio Quintero-RamosInstituto de Investigación en Inmunología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
Carlos Torres-LozanoEx Jefe del departamento de Inmunología Clínica y Alergia, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano de Seguro Social (IMSS), Guadalajara, Mexico.
Beatriz Bayardo-GutierrezDepartamento de Alergia e Inmunología Clínica Pediátrica, Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Guadalajara, Mexico.
Alejandro Barrón-BalderasDepartamento de Clínicas de la Reproducción Humana, Crecimiento y Desarrollo Infantil, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
Sergio D RosenzweigImmunology Service, Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, MD, United States.
Jennifer StoddardImmunology Service, Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, MD, United States.
Julie NiemelaImmunology Service, Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, NIH, Bethesda, MD, United States.
María Enriqueta Núñez-NúñezDepartamento de Alergia e Inmunología Clínica Pediátrica, Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Guadalajara, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Severe combined immunodeficiency (SCID) comprises a group of life-threatening inborn errors of immunity (IEI) characterized by profound T-cell deficiency, frequently accompanied by impaired B cell and natural killer (NK) cell function. X-linked SCID (X-SCID), caused by pathogenic variants in Case presentation: We describe two male siblings born to consanguineous parents with a family history of early sibling deaths due to severe infections. Patient 1 was a 9-month-old boy who developed persistent cough, chronic diarrhea, and subcutaneous nodules following Bacillus Discussion: These cases underscore the challenges faced by patients with SCID when timely access to curative therapy is not available. They also highlight the importance of readily accessible but highly informative diagnostic clues, such as the absence of a thymic shadow on chest radiography and the occurrence of severe complications following BCG vaccination. Conclusions: This report expands the known genotypic and phenotypic spectrum of SCID and reinforces the critical need for early diagnosis, appropriate genetic counseling in consanguineous families, and equitable access to newborn screening programs and curative treatments, including hematopoietic stem cell transplantation and gene therapy, in order to improve survival outcomes.

Indexed as

Interleukin Receptor Common gamma SubunitX-Linked Combined Immunodeficiency DiseasesBCG VaccineFatal OutcomeHumansInfantMaleBCG VaccineIL2RG protein, humanInterleukin Receptor Common gamma Subunitc.667 G>Tcase reportIL2RG genep.V223Frs2092258151severe combined immunodeficiencyX-linked severe combined immunodeficiency

Identifiers

PMID42058195
PMCPMC13120896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.